Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-03-23

Clinical Trial Update: Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating strategies to prevent CNS disease in children with acute lymphoblastic leukemia—radiation therapy to the head versus intrathecal chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Leukemia | Phase 3 | Status: WITHDRAWN